| Element List | Explanation |
|---|---|
| Introduction | Professional Medical Expertise Company, also Trading as (“ProMedEx”). Announces the new developments announced about "Board of Directors’ recommendation to distribute cash dividends to shareholders for the for the fiscal year 2024" The distribution date will start on Sunday 06/07/2025. The dividends will be transferred to the bank accounts linked to the shareholders’ investment portfolios. |
| Previous Announcement | Board of Directors’ recommendation to distribute cash dividends to shareholders for the for the fiscal year 2024. |
| Date of Previous Announcement on Saudi Exchange’s Website | 2025-04-13 Corresponding to 1446-10-15 |
| Hyperlink to the Previous Announcement on the Saudi Exchange Website | Click Here |
| Latest Developments Of The Announced Event | The distribution date will start on Sunday 06/07/2025. The dividends will be transferred to the bank accounts linked to the shareholders’ investment portfolios. Professional Medical Expertise Company also urges shareholders to update their data in the banking system and link bank account numbers to their investment portfolios to ensure receipt of dividends on the distribution day. |
| The costs associated with the event, and if they have changed or not with indication of the reasons. | Not applicable. |
| Additional Information | We would like to draw the attention of non-resident investors to the fact that cash dividends transferred or credited to their bank accounts will be subject to a withholding tax of 5% upon transfer or credit to their bank accounts, in accordance with the provisions of Article (68) of the Income Tax Law and Article (63) of its Executive Regulations. Professional Medical Expertise Company also urges shareholders to update their data in the banking system and link bank account numbers to their investment portfolios to ensure receipt of dividends on the distribution day. For any quires, please contact Investor Relations Department at: Phone Number: 8001240448; 301; 310; 204 Email: IR@PROMEDEX.COM |